Meno-Ease (Veggie)
Natural health product licensed in Canada
- Licence holder
- Newchieve Enterprises Inc.
- NPN or DIN-HM
- 80069616
- Status
- Inactive licence
- Licence date
- 24 May 2016
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Conditions légales
Vitex agnus-castus L.: L'étiquetage doit comporter un avertissement déconseillant l'usage chez les femmes ayant des antécédents personnels ou familiaux de cancer du sein.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Actaea racemosa L.: Seuls les extraits aqueux et hydro-alcooliques de titre faible (30 %) sont admis. La portion journalière recommandée ne doit pas conduire à une ingestion de glycosides de triterpène (calculés comme 27-déoxyactéine) supérieure à 3 mg.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Vitex agnus-castus Source : Fruit Extract : Matériel brut sec Extraction ratio : 10:1 Dry plant equivalent : 1,000 mg | 100 mg | Not calculated |
| Actaea racemosa Source : Rhizome Extraction ratio : 12:1 Dry plant equivalent : 1,200 mg | 100 mg | Not calculated |
| Extrait d'isoflavones de trèfle rouge Source : Extrait d'isoflavones de trèfle rouge | 20 EAI | Not calculated |
| Angelica sinensis Source : Racine Extract : Matériel brut sec Extraction ratio : 10:1 Dry plant equivalent : 600 mg | 60 mg | Not calculated |
| Panax quinquefolius Source : Racine Extract : Matériel brut sec Extraction ratio : 5:1 Dry plant equivalent : 250 mg | 50 mg | Not calculated |
Non-medicinal ingredients
Hypromellose
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes de sexe féminin | Not specified | 1 Capsule | 2 Tous les jours |
Uses authorised in Canada
(Traditionally) used in Herbal Medicine to help relieve the pain associated with menstruation. Used in Herbal Medicine to help relieve premenstrual symptoms. Used in Herbal Medicine as a hormone normaliser to help stabilise menstrual cycle irregularities. (Used in Herbal Medicine to) help(s) relieve symptoms associated with menopause, such as hot flashes. May reduce severe and frequent menopausal symptoms (such as hot flashes/flushes and/or night sweats).
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
If menstruation is delayed or absent, or if you experience increased menstrual bleeding time, discontinue use and consult a health care practitioner. If you are breastfeeding, consult a healthcare practitioner prior to use. If you are taking birth control pills, consult a health care practitioner prior to use. If you are taking blood thinners/ anticoagulants, consult a health care practitioner prior to use. If you are taking hormone replacement therapy (HRT), consult a health care practitioner prior to use. If you have family history of cancer, consult a healthcare practitioner prior to use. If you have a liver disorder or develop liver-related symptoms (e.g. abdominal pain, jaundice, dark urine), consult a health care practitioner prior to use. If you have a history of hormonal or gynecological disease including ovarian cancer, endometriosis and/or uterine fibroids, consult a health care practitioner prior to use. Ensure that you are up-to-date on appointed clinical tests such as mammograms and endometrial ultrasounds or biopsies before using this product. If you experience breast pain, discomfort, soreness and/or tenderness, abnormal uterine bleeding including spotting and/or recurrence of menstruation in postmenopausal women, discontinue use and consult a health care practitioner. If symptoms persist or worsen, consult a health care practitioner. If you are pregnant or breastfeeding, consult a healthcare practitioner prior to use. Consult a health care practitioner prior to use if you are taking hormone-containing medications such as progesterone preparations, oral contraceptives or hormone replacement therapy. Consult a health care practitioner prior to use if you are taking digoxin.
- Effets indésirables connus
If you experience breast pain, discomfort and/or tenderness, discontinue use and consult a health care practitioner.
- Contre-indications
If you are pregnant, do not use this product. If you have allergy/hypersensitivity to members of the Apiaceae/Umbelliferae family (anise, caraway, carrot, celery, dill, parsley), do not use this product. If you have diarrhoea or haemorrhagic diseases, do not use this product. If you have hypermenorrhoea/ profuse menstrual flow/ heavy periods, do not use this product. If you have diabetes, consult a health care practitioner prior to use. If you currently have or previously had breast cancer or if you have a predisposition to breast cancer, as indicated by an abnormal mammogram and/or biopsy, or if you have a family member with breast cancer, do not use this product.
Source
Official Health Canada record, licence 80069616
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.